×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| RPG LIFE SCIENCES LTD. | 1760.2 | 349.3 | 1727.1 | 21.12 | 3,920 | 41.0 |
| GUFIC BIOSCIENCES LTD. | 2096.58 | 193.24 | 2077.94 | 1.93 | 3859 | 47.0 |
| Thyrocare Technologies Limited | 1560.56 | 192.24 | 1525.49 | 3.51 | 3846 | 44.5 |
RPG Life Sciences Limited, with Security Code 532983, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 134.7 | 130.6 | 118.4 | 147.7 | 153.5 | 153.7 | 126.9 | 165.4 | 172.2 | 172.7 |
| Expenses | 105.1 | 101.4 | 102.6 | 115.5 | 116.3 | 115.8 | 106.3 | 126.4 | 126.3 | 123.6 |
| Operating Profit | 29.7 | 29.2 | 15.9 | 32.2 | 37.3 | 37.9 | 20.7 | 39.1 | 45.9 | 49.2 |
| OPM % | 22.06% | 22.37% | 13.43% | 21.82% | 24.28% | 24.66% | 16.32% | 23.62% | 26.67% | 28.46% |
| Other Income | 1.2 | 0.5 | 1.8 | 1.8 | 1.8 | 1.9 | 1.7 | 2.4 | -25.4 | 3.3 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
| Depreciation | 3.9 | 3.9 | 3.9 | 4.2 | 4.2 | 4.1 | 4.5 | 5.3 | 5.3 | 5.5 |
| Profit before tax | 27.0 | 25.7 | 13.8 | 29.8 | 34.8 | 35.5 | 17.7 | 36.0 | 42.4 | 46.9 |
| Tax % | 26.1% | 25.8% | 25.1% | 25.8% | 25.7% | 25.5% | 25.4% | 25.7% | 72.2% | 25.5% |
| Net Profit | 20.0 | 19.1 | 10.4 | 22.1 | 25.9 | 26.5 | 13.2 | 26.8 | 4.2 | 34.9 |
| EPS in Rs | 12.08 | 11.56 | 6.26 | 13.36 | 15.64 | 16 | 8.01 | 16.18 | 2.54 | 21.12 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 52% |
| 3 Years: | 30% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 53% |
| 3 Years: | 68% |
| 1 Year: | 46% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|